|This message contains images. If you don't see images, click here to view.|
here to advertise in this news brief.
PTCB plans major update to certification requirements
American Society of Health-System Pharmacists
The group that has certified nearly 500,000 pharmacy technicians is introducing new requirements to the process of obtaining and maintaining the certified pharmacy technician credential. "What we're doing here is raising the bar," said Everett McAllister, executive director and chief executive officer of the Pharmacy Technician Certification Board. "The goal is to always focus on the patients. That's always the ultimate goal."
| Share this article:
Register now for the AzPA Spring Clinical Symposium
Collaboration for Improvement in Patient Outcomes
Presented by the AzPA Health-System Academy
Date: Saturday, April 27
Location: Banner Desert Medical Center
Save the Date
Friday, May 3
Geriatric Pharmacy Roundtable: A Focus on Geriatric Pharmacotherapy
Midwestern University College of Pharmacy Glendale
2013 Arizona Pharmacy Association Annual Convention & Trade Show
Watch your mailbox for complete information about the 2013 Arizona Pharmacy Association Annual Convention & Trade Show, June 27-30 at the Westin La Paloma in Tucson, Ariz.
Pharmacy: A Global Profession
Not an AzPA member? Join today
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry.
Bath salts aren't just for the bathtub anymore
By Cynthia Sheppard Solomon
Another emergency room admission: overheated, strongly odorous, profusely sweating, tachycardia, severe chest pain, shortness of breath, severe agitation and paranoia. Just another day in the emergency department? A recent survey in the United Kingdom found the mean age of "bath salt" users was 25 years, often with a recreational polydrug history. These bath salts, named for their similar appearance to those chosen for bathtub pleasure, are actually chemicals of abuse in the U.S. and abroad.
Industry pulse: Have you noticed an increase in ER admissions for "bath salt" use?
Last week's survey: Do you think institutional recommendations benefit patients?
CVS launches a 'virtual pharmacy' iPad app
CVS has officially upped the ante in the pharmacy app game. At Mad*Pow’s Healthcare Experience Design Conference in Boston, CVS Caremark Chief Digital Officer Brian Tilzer announced a new CVS iPad app, just as it hit the AppStore. The CVS iPad app presents the user with a 3-D virtual pharmacy, where each section of the store corresponds to a functionality for the app, many of which were already present on CVS's iPhone app. In the pharmacy, users can scan barcodes to refill prescriptions and manage their family's prescriptions.
The improved pharmacy business
In case you haven't noticed, pharmacy stocks are on the rise. Over the last three months we've seen Walgreen Company rise 27 percent, CVS Caremark Corporation up 12 percent and Rite Aid Corporation higher by 50 percent. The reason is because of a generic shift where margins and operating cash flow is increasing. Despite this increase, all still operate with incredibly tight margins, as the cash flow returns for diversified pharmacies remain a challenge.
Politicians may doctor Gov. Deval Patrick's pharmacy bill
Lawmakers will examine Gov. Deval Patrick's compounding pharmacy bill and may add their own measures as they try to plug regulatory loopholes revealed by the deadly nationwide fungal meningitis outbreak tied to Framingham, Mass.-based New England Compounding Center.
Behavioral symptoms in dementia require measured approach
Pharmacy Practice News
Pharmacists, working as part of a healthcare team, should be conservative when treating behavioral and psychological symptoms associated with dementia, according to a presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting. When patients present to the emergency department or are admitted to a hospital floor or long-term care facility with signs of delirium, dementia or mental status changes, clinicians should initiate a stepwise process to patient evaluation and management, said Christopher Thomas, a clinical pharmacy specialist in psychiatry.
Want to be published?
In an effort to enhance the overall content of Pharmacy Flash, we'd like to include peer-written articles in future editions. As a member of the pharmaceutical industry, your knowledge lends itself to unprecedented expertise. And we're hoping you'll share this expertise with your peers through well-written commentary. Because of the digital format, there's no word or graphical limit and our group of talented editors can help with final edits. If you're interested in participating, please contact Ronnie Richard to discuss logistics.
Parents will push for medication, even if doctor says not needed
When doctors use quick-and-easy disease labels to sum up symptoms of concern in an otherwise healthy infant, parents are more apt to want to treat their child with some type of medication, even if they're told that drugs won't help, new research says.
Contraception and headache
Most women have used at least one method of contraception during their reproductive years, with the majority favoring combined oral contraceptives. Women are often concerned about the safety of their method of choice and also ask about likely effects on their pre-existing headache or migraine and restrictions on using their headache medication.
NECC crisis shifts focus to hospital sterile preparation
Pharmacy Practice News
The same quality flaws that have come to light in Massachusetts' crackdown on sterile compounding pharmacies also may exist in many hospital pharmacies that formulate sterile preparations, according to a recent survey by the Institute for Safe Medication Practices. Seventy-four percent of 412 survey respondents — most of them pharmacists — reported that contamination could be a risk for their facilities, and 13 percent said that contamination actually had occurred during the past year.
Experts recommend against calcitonin-salmon for postmenopausal osteoporosis
American Society of Health-System Pharmacists
The benefits of calcitonin-salmon for the treatment of postmenopausal osteoporosis are minimal and do not outweigh an uncertain cancer risk associated with the drug, a slim majority of FDA advisers concluded March 5. The 12-9 vote by members of FDA's Drug Safety and Risk Management Advisory Committee and the Advisory Committee for Reproductive Health Drugs was in line with a decision reached last July by European regulators.
UPS to forfeit $40 million over illegal online pharmacy shipments
United Parcel Service Inc. has agreed to forfeit $40 million it earned from illegal Internet pharmacies shipping drugs using its services, U.S. authorities recently said. As part of the settlement, UPS entered a nonprosecution agreement with the U.S. Department of Justice.
Missed last week's issue? See which articles your colleagues read most.
FDA approves 1st in new class of Type 2 diabetes drugs
HealthDay News via WVNY-TV
The first in a new class of Type 2 diabetes drugs was recently approved by the FDA. Invokana tablets are to be taken in tandem with a healthy diet and exercise to improve blood sugar control in adults with Type 2 diabetes.
FDA mulls immunotherapy pill that reduces allergies over time
The Associated Press via CBS News
Drugmaker Merck & Co. recently said that federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving the sneezing and itching. The treatment, a tablet that quickly dissolves under the tongue, could become the first alternative available in the U.S. to getting a long series of uncomfortable allergy shots.
Pfizer's drug to treat tuberculosis in short supply
The FDA has added Pfizer Inc.'s tuberculosis treatment rifampin to its list of drugs in short supply, the latest in a growing number of spottily available TB medications. The FDA noted in a post on its website that the injectable antibiotic will be in short supply until the end of June. The cause of the shortage is a manufacturing delay, it said.
AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit
Danielle Wegert, Content Editor, 469.420.2696
Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.
This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
April 2, 2013
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063